Home > The best places to buy Chembio Diagnostics stock after its 220% rise

The best places to buy Chembio Diagnostics stock after its 220% rise

Chembio Diagnostics (NASDAQ: CEM) stock is undeniably hot right now, and the company’s share price surge might not be over just yet.

If you want to invest in Chembio Diagnostics, you have come to the right place. This article details absolutely everything you need to know to make an informed investment. Scroll down to find out what the company is, why its stock price is surging in value, and what our price forecast is for CEM shares in the coming years.

Before we delve into any of that, check out the section directly below for our analysts’ selection of the best places to buy, sell and trade Chembio Diagnostics shares in the UK and internationally.

How & where to buy Chembio Diagnostics stock online

To buy CEM stock quickly, affordably and easily, you should click on one of the links below. After filling out a little information and funding your account, you will be ready to buy CEM shares through one of the top stockbrokers.

Here is our selection of the best platforms to buy Chembio Diagnostics shares right now:


eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.

Register with eToro instantly


Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What is Chembio Diagnostics and why is its share price surging?

Founded in 1985 and headquartered in Hauppauge, New York, it is a medical company that develops, manufactures, and commercialises point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company’s main covered diseases include HIV, Syphilis, Zika virus, and indeed COVID-19.

Chembio is listed on the Nasdaq stock exchange under the ticker, CEM.

The reason that CEM stock has surged in value is because of bullish market sentiment following a $28.3 million purchase order from Bio-Manguinhos for Chembio’s DPP SARS-CoV-2 antigen tests for delivery during 2021. Many feel this demonstrates the company’s credentials to formalise arrangements with major strategic partners.

Should I buy CEM stock today?

If you believe this latest deal could herald a new era of growth to the company, buying the news by purchasing shares could be a smart move. However, make sure you conduct all of the necessary research to inform your investment first.

CEM price target 2021

Our Chembio Diagnostics price target for 2021 and beyond is as follows: a 12-month high of $8, a median of $6 and a low of $4.

Trade/invest in stocks with just $50
Invest for dividends and get payout on stocks on Ex-Dividend day
Over 11 payment methods, including PayPal
Open my Account

We use cookies to personalise content & ads, provide social media features and offer you a better experience. By continuing to browse the site or clicking "OK, Thanks" you are consenting to the use of cookies on this website.